Cuidong Bian

389 Xincun Road
Xincun, 200065, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

The clinical efficacy and limitations of dutasteride-regulated abiraterone metabolism in abiraterone-resistant patients: a prospective single-arm clinical trial in Chinese patients.

The clinical efficacy and limitations of dutasteride-regulated abiraterone metabolism in abiraterone-resistant patients: a prospective single-arm clinical trial in Chinese patients.

Journal: Translational andrology and urology

Published: June 27, 2022

Identification of hub genes predicting the development of prostate cancer from benign prostate hyperplasia and analyzing their clinical value in prostate cancer by bioinformatic analysis.

Identification of hub genes predicting the development of prostate cancer from benign prostate hyperplasia and analyzing their clinical value in prostate cancer by bioinformatic analysis.

Journal: Discover oncology

Published: March 21, 2022

Serum prolactin level as a predictive factor for abiraterone response in patients with metastatic castration-resistant prostate cancer.

Serum prolactin level as a predictive factor for abiraterone response in patients with metastatic castration-resistant prostate cancer.

Journal: The Prostate

Published: March 18, 2022

Management of prostate cancer by targeting 3βHSD1 after enzalutamide and abiraterone treatment.

Management of prostate cancer by targeting 3βHSD1 after enzalutamide and abiraterone treatment.

Journal: Cell reports. Medicine

Published: December 08, 2021

Tracing steroidogenesis in prostate biopsy samples to unveil prostate tissue androgen metabolism characteristics and potential clinical application.

Tracing steroidogenesis in prostate biopsy samples to unveil prostate tissue androgen metabolism characteristics and potential clinical application.

Journal: The Journal of steroid biochemistry and molecular biology

Published: February 21, 2021

Long noncoding RNA POU3F3 promotes cancer cell proliferation in prostate carcinoma by upregulating rho-associated protein kinase 1.

Long noncoding RNA POU3F3 promotes cancer cell proliferation in prostate carcinoma by upregulating rho-associated protein kinase 1.

Journal: Journal of cellular biochemistry

Published: September 27, 2018

Downregulation of lnRNA-NEF is involved in the postoperative cancer distant recurrence in prostate carcinoma patients.

Downregulation of lnRNA-NEF is involved in the postoperative cancer distant recurrence in prostate carcinoma patients.

Journal: Journal of cellular biochemistry

Published: September 21, 2018

Sleeve Gastrectomy Reversed Obesity-Induced Hypogonadism in a Rat Model by Regulating Inflammatory Responses in the Hypothalamus and Testis.

Sleeve Gastrectomy Reversed Obesity-Induced Hypogonadism in a Rat Model by Regulating Inflammatory Responses in the Hypothalamus and Testis.

Journal: Obesity surgery

Published: March 07, 2018

A preliminary clinical study of endoscopic minimally-invasive surgery in urethral stricture complicated with false passage.

A preliminary clinical study of endoscopic minimally-invasive surgery in urethral stricture complicated with false passage.

Journal: SpringerPlus

Published: January 10, 2016

A comparative study of diode laser and plasmakinetic in transurethral enucleation of the prostate for treating large volume benign prostatic hyperplasia: a randomized clinical trial with 12-month follow-up.

A comparative study of diode laser and plasmakinetic in transurethral enucleation of the prostate for treating large volume benign prostatic hyperplasia: a randomized clinical trial with 12-month follow-up.

Journal: Lasers in medical science

Published: January 03, 2016

MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.

MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 30, 2014

Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.

Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.

Journal: BJU international

Published: June 08, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026